Back

Which drugs to select and which to avoid in a patient with microalbuminuria

29 August 2026 (18:15 - 18:30)
Organised by: Logo
Congress Presentation Part of: Albuminuria as a clinical compass: guideline-driven approaches to cardiorenal protection Risk Factors and Prevention ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Pauline Anne Swift

Epsom and St Helier NHS Trust Hospital, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Testing for albuminuria to prevent cardiovascular disease
Professor R. Gansevoort (Groningen, NL)
Slides Video
Presentation thumbnail
Albuminuria-based guideline implementation to improve cardiovascular outcomes
Professor C. Wanner (Wuerzburg, DE)
Slides Video
Presentation thumbnail
How to manage albuminuria in primary care
Doctor S. Claudel (Boston, US)
Slides Video

Access the full session

Session thumbnail
Albuminuria as a clinical compass: guideline-driven approaches to cardiorenal protection
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 18:15 CET
You may be interested in
thumbnail
Congress Session
A new era in the management of patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) and cardiovascular complications
31 August 2024
thumbnail
Congress Presentation
Effects on albuminuria and blood pressure after radiofrequency renal denervation: two-year results from the Global SYMPLICITY Registry DEFINE
31 August 2026
thumbnail
Congress Session
How to optimise RAASi therapy
23 May 2022
thumbnail
Congress Presentation
Risk management in chronic kidney disease
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources